WebinarFebruary 20, 2025 from 12:00 pm to 1:00 pm EST
Learn the latest advancements in the understanding and management of IgA Nephropathy (IgAN) with two expert-led videos sponsored by Otsuka with Professors Brad Rovin, MD (United States) and Jürgen Floege,… Read More
This presentation for patients will discuss how Polycystic Kidney Disease (PKD) develops, how the disease changes over time, and how it affects patients both physically and mentally. Read More
Through the lens of renal pathology, this webinar will provide insights into the histopathological features that are crucial for accurate diagnosis and risk stratification in IgA Nephropathy, highlighting the significance… Read More
This presentation discusses the foundational aspects of motivational interviewing, basic counseling techniques, and the importance of this collaborative counseling method in this population. Read More
This presentation for patients will discuss how Polycystic Kidney Disease (PKD) develops, how the disease changes over time, and how it affects patients both physically and mentally. Read More
This presentation will review the impact of kidney disease in the United States and the importance of the kidneys and preserving kidney function. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.